Blueprint Medicines Corporation

NasdaqGS:BPMC Stock Report

Market Cap: US$6.8b

Blueprint Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BPMC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 25SellUS$431,834Becker HewesIndividual4,863US$88.80
05 Mar 25SellUS$313,464Percy CarterIndividual3,530US$88.80
05 Mar 25SellUS$117,749Ariel HurleyIndividual1,326US$88.80
05 Mar 25SellUS$331,490Philina LeeIndividual3,733US$88.80
05 Mar 25SellUS$457,942Debra Durso-BumpusIndividual5,157US$88.80
05 Mar 25SellUS$576,223Fouad NamouniIndividual6,489US$88.80
05 Mar 25SellUS$1,434,209Kathryn HavilandIndividual16,151US$88.80
05 Mar 25SellUS$469,219Michael LandsittelIndividual5,284US$88.80
05 Mar 25SellUS$576,756Christina RossiIndividual6,495US$88.80
05 Mar 25SellUS$467,266Tracey McCainIndividual5,262US$88.80
05 Mar 25SellUS$512,021Jeffrey AlbersIndividual5,766US$88.80
03 Oct 24SellUS$324,500Fouad NamouniIndividual3,633US$89.32
05 Jun 24SellUS$420,520Percy CarterIndividual4,000US$105.13
03 Jun 24SellUS$207,645Becker HewesIndividual1,951US$106.43
03 Jun 24SellUS$259,263Percy CarterIndividual2,436US$106.43

Insider Trading Volume

Insider Buying: BPMC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BPMC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders731,4551.09%
Institutions66,512,98498.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
The Vanguard Group, Inc.
6,774,884US$709.0m1.37%0.01%
9.87%
T. Rowe Price Group, Inc.
6,376,116US$667.3m3.91%0.05%
7.88%
BlackRock, Inc.
5,090,723US$532.7m-25.9%0.01%
6.63%
Wellington Management Group LLP
4,281,364US$448.0m7.99%0.06%
3.87%
State Street Global Advisors, Inc.
2,500,207US$261.6m-9.6%0.01%
3.48%
FMR LLC
2,246,527US$235.1m-50.3%0.01%
3.01%
William Blair Investment Management, LLC
1,944,695US$203.5m15.7%0.23%
2.31%
Geode Capital Management, LLC
1,490,101US$155.9m0.67%0.01%
1.95%
Macquarie Investment Management Business Trust
1,258,976US$131.8m-0.37%0.15%
1.84%
Avoro Capital Advisors LLC
1,185,000US$124.0m0%1.6%
1.83%
Pictet Asset Management Limited
1,183,682US$123.9m1.47%0.08%
1.76%
AllianceBernstein L.P.
1,138,022US$119.1m-6.54%0.03%
1.7%
Rock Springs Capital Management LP
1,096,899US$114.8m42.7%3.93%
1.6%
JP Morgan Asset Management
1,036,274US$108.4m-7.14%0.01%
1.36%
Hood River Capital Management LLC
879,932US$92.1m30.9%1.35%
1.35%
Invesco Ltd.
872,916US$91.4m7.94%0.02%
1.34%
Eventide Asset Management, LLC
862,285US$90.2m147%1.42%
1.3%
American Century Investment Management Inc
839,203US$87.8m2.96%0.04%
1.14%
Millennium Management LLC
737,364US$77.2m19.2%0.06%
1.1%
Norges Bank Investment Management
711,164US$74.4m20.1%no data
1.03%
Alkeon Capital Management, LLC
666,780US$69.8m11%0.42%
1.01%
Emerald Advisers, LLC
651,802US$68.2m-4.96%1.61%
1.01%
Citadel Advisors LLC
649,958US$68.0m735%0.06%
1%
Jacobs Levy Equity Management Inc
648,660US$67.9m30.8%0.22%
1%
Goldman Sachs Group, Investment Banking and Securities Investments
645,515US$67.6m0%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 02:07
End of Day Share Price 2025/05/02 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Blueprint Medicines Corporation is covered by 36 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colleen KusyBaird
Ishan MajumdarBaptista Research
Peter LawsonBarclays